Bioglikosp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 77 days late).
- 202515/06/2026
- 202416/06/2025
- 202314/06/2024
- 202213/07/2023
- 202130/09/2022
- 202009/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Trademarks
Biogliko holds 1 active trademark registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2020.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| BioGliko | Z.538347 | 5 | Protected | Dec 30, 2031 | |
| GLUCOMFORT(word) | Z.518835 | 5, 10 | Not registered | – |
| Mark | Protected until | |
|---|---|---|
| BioGliko | Dec 30, 2031 | |
| GLUCOMFORT(word) | – |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jacek Klocekage 60 | 525 | $14,181.52 | 50% |
Tomasz Krystian Ledwońage 59 | 525 | $14,181.52 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 29, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy | |
| Jul 24, 2019 | Aid for SME access to finance — aid for start-ups | $210.4K$210,428 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Edoktor24 Servicessp. z o.o. | $34,089.64 | edoktor24.pl | ||
| 4ATsp. z o.o. | $35,272.91 | 4at.pl | ||
| SimplicardiacS.A. | $28,951.71 | simplicardiac.com | ||
| Spektrinosp. z o.o. | $21,528.32 | spektrino.com | ||
| Unidectsp. z o.o. | $21,242.17 | univect.com | ||
| Braintechsp. z o.o. | $20,965.65 | braintech.pl | ||
| 2loop TechS.A. | $15,564.71 | 2loop.tech | ||
| HTPsp. z o.o. | $13,728.34 | htp7.pl | ||
| Renewablepowersp. z o.o. | $11,568.22 | renewablepower.pl | ||
| Microanalysissp. z o.o. | $1,425.98 | microanalysis.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-01-25 | Address change (Ul. Wałbrzyska 11/101e, 02-739, Warszawa → Ul. Świeradowska 47, 02-662, Warszawa) | |
| 2019-09-20 | Address change (Ul. Wałbrzyska 11/101e, 02-741, Warszawa → Ul. Wałbrzyska 11/101e, 02-739, Warszawa) | |
| 2019-09-20 | Share capital increase (5,000.00 PLN → 105,000.00 PLN) | |
| 2019-07-05 | Entered in the register |
FAQ
Last updated: 2026-06-15